NOTE G INCOME TAXES
The Company files its income tax returns in the U.S. federal jurisdiction, and various state jurisdictions. Income tax returns filed for the fiscal years ended March 31, 2016, 2015, and 2014 are considered open and subject to examination by tax authorities. Deferred income tax assets and liabilities are computed and recognized for those differences that have future tax consequences and will result in net taxable or deductible amounts in future periods. Deferred tax expense or benefit is the result of changes in the net asset or liability for deferred taxes. The deferred tax liabilities and assets for the Company result primarily from net operating loss and tax credit carry forwards, reserves and accrued liabilities.
At March 31, 2017, the Company has total net federal and state operating loss carry forwards of approximately $8,418,000, which expire in various amounts at dates from 2017 through 2032. There are certain limitations to the use and application of these items. Management reviews net operating loss carry forwards and income tax credit carry forwards to evaluate if those amounts are recoverable. After a review of projected taxable income and the components of the deferred tax assets in accordance with applicable accounting guidance it was determined that it is more likely than not that the tax benefits associated with the remaining components of the deferred tax assets will not be realized. This determination was made based on the Company’s history of losses from operations and the uncertainty as to whether the Company will generate sufficient taxable income to use the deferred tax assets prior to their expiration. Accordingly, a valuation allowance was established to fully offset the value of the deferred tax assets. Our ability to realize the tax benefits associated with the deferred tax assets depends primarily upon the timing of future taxable income and the expiration dates of the components of the deferred tax assets. If sufficient future taxable income is generated, we may be able to offset a portion of future tax expenses.
The reconciliation between the statutory federal income tax provision and the actual effective tax provision is as follows:
| | | Years ended March 31, | |
| | | 2017 | | 2016 | |
| Federal benefit at statutory rate (34%) before loss carry-forward | | $ | (700,027) | | $ | (726,849) | |
| Non-repatriated loss of Hong Kong Joint Venture | | | 345,953 | | | 252,228 | |
| Permanent differences | | | 57,651 | | | 83,024 | |
| State income tax benefit net of federal effect | | | (30,515) | | | (38,815) | |
| Expiration of tax credits | | | 251,520 | | | 243,043 | |
| Increase in deferred tax valuation allowance | | | 75,418 | | | 187,369 | |
| | | $ | - | | $ | - | |
The individual components of the Company’s deferred tax assets are as follows:
| | | March 31, | |
| | | 2017 | | 2016 | |
| Deferred tax assets: | | | | | | | |
| Accruals and allowances | | $ | 58,558 | | $ | 57,922 | |
| Inventory uniform capitalization | | | 17,966 | | | 26,309 | |
| Net operating loss carry forward | | | 3,156,643 | | | 2,821,998 | |
| Foreign tax credit carry forward | | | 695,827 | | | 947,347 | |
| Research and development tax credit carry forward | | | 61,701 | | | 61,701 | |
| Allowance for unrealizable deferred tax assets | | | (3,990,695) | | | (3,915,277) | |
| Net deferred tax asset | | $ | - | | $ | - | |